As I watched my husband walk up the beach on our winter sun holiday last month, I felt, if I'm being painfully honest, disgusted. By contrast, I felt the most confident I've been in years.

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

When investors are paying such high price tags for a stock, expectations are high, and any kind of miss can result in a steep ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Weight loss is a common goal for many, and while diet and exercise remain essential, some turn to medications like Mounjaro ...

Tori Spelling's alarming weight loss has sparked growing concerns, with many fearing her drastic transformation could be ...

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...